Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
62.99
+0.53 (0.85%)
Mar 6, 2026, 4:00 PM EST - Market closed
Inspire Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 911.98 | 802.8 | 624.8 | 407.86 | 233.39 | Upgrade
|
| Revenue Growth (YoY) | 13.60% | 28.49% | 53.19% | 74.75% | 102.28% | Upgrade
|
| Cost of Revenue | 133.23 | 122.99 | 96.58 | 66.12 | 33.28 | Upgrade
|
| Gross Profit | 778.76 | 679.82 | 528.22 | 341.74 | 200.12 | Upgrade
|
| Selling, General & Admin | 624.64 | 529.61 | 451.96 | 320.69 | 202.62 | Upgrade
|
| Research & Development | 103.17 | 114.13 | 116.54 | 68.65 | 37.35 | Upgrade
|
| Operating Expenses | 727.8 | 643.74 | 568.49 | 389.33 | 239.97 | Upgrade
|
| Operating Income | 50.95 | 36.08 | -40.27 | -47.59 | -39.85 | Upgrade
|
| Interest Expense | -0.14 | -0.02 | - | -1.68 | -2.13 | Upgrade
|
| Interest & Investment Income | 17.54 | 23.25 | 20.56 | 5.05 | 0.13 | Upgrade
|
| Currency Exchange Gain (Loss) | -1 | -0.9 | -0.2 | -0.1 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -1.66 | 0.05 | 0.01 | 0.05 | -0.12 | Upgrade
|
| Pretax Income | 65.7 | 58.45 | -19.91 | -44.27 | -41.97 | Upgrade
|
| Income Tax Expense | -79.73 | 4.94 | 1.25 | 0.61 | 0.07 | Upgrade
|
| Net Income | 145.42 | 53.51 | -21.15 | -44.88 | -42.04 | Upgrade
|
| Net Income to Common | 145.42 | 53.51 | -21.15 | -44.88 | -42.04 | Upgrade
|
| Net Income Growth | 171.77% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 29 | 30 | 29 | 28 | 27 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 31 | 29 | 28 | 27 | Upgrade
|
| Shares Change (YoY) | -2.57% | 4.24% | 4.38% | 2.97% | 4.56% | Upgrade
|
| EPS (Basic) | 4.95 | 1.80 | -0.72 | -1.60 | -1.54 | Upgrade
|
| EPS (Diluted) | 4.89 | 1.75 | -0.72 | -1.60 | -1.54 | Upgrade
|
| EPS Growth | 179.43% | - | - | - | - | Upgrade
|
| Free Cash Flow | 78.48 | 91.12 | 1.02 | 2.47 | -24.79 | Upgrade
|
| Free Cash Flow Per Share | 2.64 | 2.98 | 0.04 | 0.09 | -0.91 | Upgrade
|
| Gross Margin | 85.39% | 84.68% | 84.54% | 83.79% | 85.74% | Upgrade
|
| Operating Margin | 5.59% | 4.50% | -6.44% | -11.67% | -17.07% | Upgrade
|
| Profit Margin | 15.95% | 6.67% | -3.39% | -11.00% | -18.01% | Upgrade
|
| Free Cash Flow Margin | 8.61% | 11.35% | 0.16% | 0.61% | -10.62% | Upgrade
|
| EBITDA | 64.91 | 42.63 | -37.43 | -45.73 | -38.63 | Upgrade
|
| EBITDA Margin | 7.12% | 5.31% | -5.99% | -11.21% | -16.55% | Upgrade
|
| D&A For EBITDA | 13.96 | 6.55 | 2.85 | 1.86 | 1.22 | Upgrade
|
| EBIT | 50.95 | 36.08 | -40.27 | -47.59 | -39.85 | Upgrade
|
| EBIT Margin | 5.59% | 4.50% | -6.44% | -11.67% | -17.07% | Upgrade
|
| Effective Tax Rate | - | 8.46% | - | - | - | Upgrade
|
| Advertising Expenses | 114.9 | 94.9 | 100.3 | 74.3 | 47.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.